ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,769Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 434

$702K Total Retail Price of All Prescriptions

Rank: 16 out of 434

811 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 811 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 811 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 9,819 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LEVOTHYROXINE SODIUM 656 532 1 3
LISINOPRIL 585 514 2 1
LOVASTATIN 430 362 3 10
HYDROCODONE-ACETAMINOPHEN 418 324 S3 4 4
SIMVASTATIN 418 339 4 2
OMEPRAZOLE 410 327 6 5
ZOLPIDEM TARTRATE 253 186 7 11
METFORMIN HCL 245 202 8 7
METOPROLOL TARTRATE 227 190 9 12
FUROSEMIDE 221 172 10 9
GABAPENTIN 214 169 11 14
CITALOPRAM HBR 208 153 12 23
ATORVASTATIN CALCIUM 206 148 13 19
ALENDRONATE SODIUM 175 154 14 15
AMLODIPINE BESYLATE 158 129 15 6
LOSARTAN POTASSIUM 157 131 16 13
HYDROCHLOROTHIAZIDE 156 147 17 8
POTASSIUM CHLORIDE 155 128 18 20
TRAMADOL HCL 152 128 19 28
OXYCODONE HCL 150 76 S2 20 34
PANTOPRAZOLE SODIUM 141 112 21 66
PRAVASTATIN SODIUM 136 111 22 17
VENTOLIN HFA 132 86 23 30
FLUTICASONE PROPIONATE 119 92 24 26
SERTRALINE HCL 117 87 25 27
METOPROLOL SUCCINATE 114 109 26 22
RANITIDINE HCL 112 91 27 31
AZITHROMYCIN 108 87 28 38
ATENOLOL 103 93 29 16
DONEPEZIL HCL 103 98 29 35
SPIRIVA 97 78 31 36
CIPROFLOXACIN HCL 96 76 32 55
PAROXETINE HCL 94 51 33 61
WARFARIN SODIUM 93 86 34 18
BACLOFEN 91 76 35 77
CLOPIDOGREL 89 75 36 41
TRAZODONE HCL 88 70 37 33
HYDRALAZINE HCL 87 79 38 79
PROAIR HFA 87 56 38 60
GEMFIBROZIL 86 59 40 62
ADVAIR DISKUS 84 53 41 52
ALLOPURINOL 80 56 42 25
BENAZEPRIL HCL 80 60 42 49
OXYBUTYNIN CHLORIDE 79 79 44 82
CARVEDILOL 78 55 45 24
PREDNISONE 77 61 46 42
PLAVIX 77 68 46 64
BUPROPION HCL SR 72 42 48 129
ROPINIROLE HCL 70 65 49 104
MORPHINE SULFATE ER 69 18 S2 50 50
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 51 51 21
LOSARTAN-HYDROCHLOROTHIAZIDE 57 50 52 39
TRIAMCINOLONE ACETONIDE 57 42 52 94
TRIAMTERENE-HCTZ 56 53 54 47
LANTUS 53 46 55 80
ACYCLOVIR 52 31 56 125
TAMSULOSIN HCL 51 40 57 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.